Short Courses on Utilizing the NIH Stage Model to Develop Behavioral Interventions to Promote Healthy Aging (R25 - Independent Clinical Trial Not Allowed)
ID: 355832Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $350K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355832

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-029.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced a funding opportunity for short courses aimed at utilizing the NIH Stage Model to develop behavioral interventions that promote healthy aging. The initiative seeks to create a comprehensive curriculum that covers the six stages of intervention development, from basic science to dissemination and implementation research, with a focus on enhancing participants' skills in creating effective, culturally competent interventions. This program is particularly significant as it addresses the growing need for evidence-based behavioral interventions for older adults, with an anticipated funding amount of $756,000 for FY 2025 to support up to two research education awards. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with a submission deadline of October 8, 2024.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AG-25-029-Full-Announcement.html
    RFA-AG-25-029.html
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), has announced a funding opportunity for short courses focused on utilizing the NIH Stage Model to develop behavioral interventions aimed at promoting healthy aging. This initiative, under the R25 Education Projects, invites applications for educational activities that enhance understanding of biomedical and behavioral research relevant to older adults. Key objectives include creating a short course curriculum that facilitates skills development across six stages of intervention—ranging from basic behavioral science to dissemination and implementation research. The curriculum must cover essential topics, such as understanding the NIH Stage Model, mechanisms of behavior change, and evaluating intervention fidelity. The program aims to enhance participants' abilities to develop effective, evidence-based interventions that are culturally competent and scalable. With an anticipated funding of $756,000 for FY 2025, the NIH seeks to support up to two research education awards, emphasizing the importance of diversity in participant recruitment. Proposals must demonstrate a commitment to fostering an inclusive research environment and include a robust evaluation and dissemination plan for the short courses developed. The primary goal is to equip researchers with essential skills to contribute to the growing field of behavioral intervention research for healthy aging.
    Similar Opportunities
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)" aimed at advancing the science of aging through innovative research infrastructure. This initiative invites applications from a diverse range of eligible institutions to develop sustainable frameworks that address critical interdisciplinary questions in aging, with a focus on areas such as machine learning applications, health disparities, and behavioral aspects of aging. The funding mechanism provides up to five years of support, including two years for initial developmental activities and up to three years for expanded activities, with an award ceiling of $500,000. Interested applicants can find more information and application guidelines at the NIH website, and must submit their proposals by December 2, 2025, to be considered for this discretionary grant opportunity.
    Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional), a federal grant opportunity aimed at funding research for developing and testing behavioral treatments for substance use and dependence. This initiative seeks to encourage research that tests the efficacy of behavioral interventions, examines mechanisms of behavior change, and optimizes treatment approaches, particularly for individuals with comorbidities and those in drug abuse treatment. The program is crucial for advancing substance abuse treatment and addressing health disparities, with a maximum funding amount of $450,000 available over three years. Interested applicants, including various educational institutions and community organizations, must submit their proposals by March 21, 2025, and can find additional information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies" (R61/R33 - Clinical Trial Optional) aimed at advancing interdisciplinary research in aging. This initiative encourages applicants to develop novel research infrastructure that addresses critical questions in aging through collaborative efforts across various disciplines, including biological aging and behavioral science. The funding is structured in two phases, providing up to $500,000 annually for initial activities over two years (R61) followed by three years for expanded activities (R33), with applications accepted from eligible institutions and organizations until December 3, 2025. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-218.html.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multidisciplinary research on HIV/AIDS and aging through the R21 Exploratory/Developmental Research Grant program. This initiative invites applications that aim to enhance the understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, with specific objectives to improve prevention, testing, treatment strategies, and management of HIV-related health issues in diverse populations, particularly older adults aged 70 and above. The grant provides funding of up to $275,000 for a two-year period, with key submission dates starting April 4, 2024, and a closing date for applications set for January 7, 2027. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled the Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) aimed at advancing research in behavioral and integrative treatments for substance use and dependence. This program encourages the development and testing of innovative behavioral therapies through a structured approach that includes intervention generation, efficacy testing in research settings, and real-world efficacy assessments, with a focus on diverse populations and the use of technology. The funding amount is contingent on NIH appropriations, with a maximum project period of five years, and applications are due by February 5, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-299.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Facilitating Preclinical and Early Phase Human Studies for New Therapeutics (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for facilitating preclinical and early phase human studies for new therapeutics, specifically targeting aging-related conditions. This initiative aims to advance T1 translational aging research, focusing on therapeutics that progress from preclinical stages to first-in-human trials, addressing conditions such as sarcopenia and heart failure with preserved ejection fraction (HFpEF). The funding opportunity, categorized under health-related activities, will utilize the UG3/UH3 Cooperative Agreement mechanism, with an estimated total program funding of $2.5 million. Interested applicants should prepare to submit their applications by fall 2024, with the NOFO expected to be published in summer 2024 and awards anticipated by July 2025.
    Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for Complex Integrated Multi-Component Projects in Aging Research, designated as a U19 Clinical Trial Optional grant. This initiative aims to support large-scale, multidisciplinary research projects that address common questions related to aging, encouraging collaboration among investigators from various institutions. The program is particularly significant as it seeks to advance scientific knowledge in aging while addressing health disparities and promoting innovative research approaches. Interested applicants, including higher education institutions, nonprofits, and government agencies, can submit proposals until September 25, 2025, with a maximum project period of five years. For further inquiries, applicants may contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-213.html.
    Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-054) aimed at advancing interdisciplinary research in aging through the development and utilization of novel research infrastructures. This initiative encourages applicants to propose projects that enhance the understanding of aging by fostering collaborations across various scientific disciplines, with a focus on producing tangible scientific results such as new knowledge or tools. The funding is particularly relevant for addressing significant aging-related questions and improving the management of age-related health issues. Eligible applicants include higher education institutions, nonprofits, and government entities, with a funding ceiling of $500,000 and a close date for applications set for December 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for New Institutional Training Programs for Aging Research (T32, Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for new institutional training programs focused on aging research, specifically under the T32 grant mechanism, which does not allow clinical trials. The initiative aims to establish training programs that will cultivate a diverse pool of highly trained scientists to meet the nation's biomedical, behavioral, and clinical research needs in aging. This funding is critical as it supports predoctoral and postdoctoral research training, enhancing existing programs through tailored coursework and mentored research experiences. The estimated total program funding is $1,188,000, with three awards anticipated. The Notice of Funding Opportunity (NOFO) is expected to be published in February 2025, with applications due by May 2025, and awards projected to be made by March 2026.
    NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) to support investigator-initiated multi-site interventional clinical trials focused on aging-related research. This funding opportunity aims to foster innovative biomedical and behavioral studies that address the complexities of aging, particularly in populations with multiple chronic conditions and polypharmacy. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with an emphasis on rigorous trial designs that ensure ethical considerations and participant diversity. Interested parties should note that the application deadline is January 7, 2026, and further details can be found at the provided NIH grants link, with inquiries directed to grantsinfo@nih.gov.